English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Conferences
Conferences
Sign up for latest coverage
Submit your event
Conferences
e
cancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Search conferences
Category
All
Disease Areas
Patient Care
Policy
Prevention & screening
Treatments
Sub-category
All
Region
All
Asia
Middle East and North Africa
Europe
North America
Central America and the Caribbean
South America
Africa
Australia and Oceania
Antarctica
Country
All
Year
All
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Keyword
Share :
2010 ASCO Annual Meeting
4 - 8 Jun 2010
Netherlands
Videos
Sarah Cannon Research Institute research developments at ASCO 2010
Dr Howard Burris, The Sarah Cannon Research Institute, Nashville
4 Feb 2011
The TOPICAL trial
Dr Siow Ming Lee, University College London, UK
3 Aug 2010
Optimising adjuvant therapy in the treatment of early stage endometrial cancer...
Dr Carien Creutzberg - Leiden University Medical Center, Netherlands
2 Aug 2010
Costs and benefits of bone metastases therapies
Professor Robert Coleman, Weston Park Hospital, Sheffield, UK
23 Jul 2010
Factors influencing the choice of bone metastases treatment
Professor Robert Coleman, Weston Park Hospital, Sheffield, UK
23 Jul 2010
Targeted therapy for bone metastases
Professor Robert Coleman, Weston Park Hospital, Sheffield, UK
23 Jul 2010
Key advances in ovarian cancer from ASCO 2010
Dr Prof Jonathan Ledermann - UCL Cancer Institute, UK
22 Jul 2010
The launch of Sarah Cannon Research UK and research developments at ASCO 2010
Dr Jeffrey Infante - Sarah Cannon Research Institute, USA
22 Jul 2010
Early diagnosis of amyloidosis
Dr Giampaolo Merlini - University of Pavia, Italy
22 Jul 2010
Ovarian cancer research
Professor Stan Kaye - Institute of Cancer Research, London, UK
20 Jul 2010
Systemic therapy - what lies ahead?
Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France
20 Jul 2010
An immunotherapy approach to pancreatic cancer
Dr Gregory Beatty - University of Pennsylvania, USA
20 Jul 2010
The PRIMA study
Prof Gilles Salles - Universite Claude Bernard Lyon, France
20 Jul 2010
Biotherapy Development Association
Prof Heinz Zwierzina - Innsbruck Medical University, Austria
20 Jul 2010
PARP inhibitors
Professor Hilary Calvert - University College London, UK
20 Jul 2010
Advances in melanoma treatment
Prof John Wagstaff - University of Swansea, Wales
20 Jul 2010
Potential biologic causes of the racial survival disparity seen in breast cancer
Prof Kathy Albain - Loyola University Chicago, USA
20 Jul 2010
Advances in the treatment of melanoma
Prof Alexander Eggermont - Erasmus University of Rotterdam, Netherlands
20 Jul 2010
The role of radiotherapy in the treatment of locally advanced prostate cancer
Prof Malcolm Mason - Cardiff University, Wales
20 Jul 2010
Drug developments presented at ASCO 2010
Dr Silvia Marsoni - Mario Negri Institute, Milan, Italy and Prof Filippo de...
20 Jul 2010
Geriatric oncology
Prof Matti Aapro - Clinique de Genolier in Genolier, Switzerland
20 Jul 2010
Phase III clinical trials at ASCO 2010
Prof Patrick Schöffski - Catholic University Leuven, Belgium
20 Jul 2010
The ASCO/ECCO joint symposium
Prof Michael Baumann - University of Technology, Dresden, Germany
20 Jul 2010
Breast cancer research from ASCO 2010
Dr Susanne Briest - University of Leipzig, Germany
20 Jul 2010
The impact of radiotherapy on patients with high risk localised prostate cancer
Prof Wendy Parulekar - Queen's University, Canada
20 Jul 2010
ALK mutation related non-small cell lung cancer
Prof George Demetri - Harvard Medical School, USA
20 Jul 2010
Targeted therapy in sarcoma treatment
Prof Gary Schwartz -Memorial Sloan-Kettering Cancer Center, New York, USA
20 Jul 2010
Prognostic and predictive markers in breast cancer
Dr Christoph Thomssen - Martin-Luther University, Halle, Germany
20 Jul 2010
Views on the joint ASCO-ASH education session
Dr Elisabeth Pitterman - Hanusch Hospital, Vienna, Austria
15 Jul 2010
Views on the joint ASCO-ASH education session
Dr Elisabeth Pitterman - Hanusch Hospital, Vienna, Austria
15 Jul 2010
The efficacy of denosumab and zoledronic acid as treatment for prostate cancer
Dr Karim Fizazi - Institut Gustave Roussy, France
8 Jul 2010
Circulating tumour cells in breast cancer
Dr Brigitte Rack, Munich University Hospital, Germany
8 Jul 2010
The influence of zoledronic acid on the treatment of endocrine-responsive early...
Prof Michael Gnant - Medical University of Vienna, Austria
7 Jul 2010
Frontline treatments for lymphomas
Professor Bruce Cheson, Lombardi Comprehensive Cancer Center, Washington DC, USA
6 Jul 2010
Clinical trial Design: Comparator arms
Prof David Cameron, Dr Christopher M Nutting, Dr Ruth Pettengell, Professor...
30 Jun 2010
New agent eribulin prolongs survival in metastatic breast cancer
Professor Chris Twelves - St James's Hospital, Leeds, UK
30 Jun 2010
Primary end points of clinical trials - overall survival versus progression...
Prof David Cameron, Prof Patrick Schöffski, Prof Hilary Calvert
30 Jun 2010
Results of the multiple myeloma study comparing zoledronic acid to clodronate
Prof Gareth Morgan - Institute of Cancer Research, Sutton, UK
25 Jun 2010
The efficacy of bendamustine and rituximab in the treatment of indolent...
Dr Mathias Rummel - University Hospital, Giessen, Germany
25 Jun 2010
NKTR-102: a new drug for treating platinum-resistant or refractory ovarian...
Professor Ignace Vergote - Catholic University of Leuven, Belgium
25 Jun 2010
Conatumumab or AMG 479 as treatment for pancreatic cancer
Prof Hedy Kindler - University of Chicago, USA
25 Jun 2010
Roundup of the 2010 ASCO conference
Prof Gordon McVie - European Institute of Oncology, Milan
11 Jun 2010
Breast cancers that spread to the liver may change biology, impacting treatment...
Dr Giuseppe Curigliano - European Institute of Oncology, Milan, Italy
11 Jun 2010
Antibody drug ipilimumab improves long-term survival in previously treated...
Dr Steven O'Day - The Angeles Clinic and Research Institute, Santa Monica...
11 Jun 2010
ALK inhibitor shows high response rate in patients with advanced NSCLC...
Prof Yung-Jue Bang - Seoul National University College of Medicine, Seoul, Korea
11 Jun 2010
New agent, eribulin, derived from marine sponge, increases survival among women...
Prof Christopher Twelves - Leeds Institute of Molecular Medicine and St...
11 Jun 2010
More from
e
cancer